Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
نویسندگان
چکیده
منابع مشابه
Nonmuscle-invasive and Muscle-invasive Urinary Bladder Cancer
This study compared the imaging quality, diagnostic accuracy, and apparent diffusion coefficient (ADC) values of reduced field-of-view (rFOV) diffusion-weighted imaging (DWI) and full field-of-view (fFOV) single-shot echo-planar imaging with regard to patients with nonmuscle-invasive or muscle-invasive bladder cancer.Thirty-nine patients with 60 bladder tumors underwent rFOV and fFOV DWI in thi...
متن کاملPredictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
Bladder cancer is a major cause of morbidity and mortality. At initial diagnosis, 75% of patients present with non-muscle-invasive disease and 25% of patients have muscle-invasive or metastatic disease.Patients with noninvasive disease suffer from a high rate of recurrence and 10-30% will have disease progression. Patients with muscle-invasive disease are primarily treated with radical cystecto...
متن کاملMetabolomics analysis reveals distinct profiles of nonmuscle‐invasive and muscle‐invasive bladder cancer
Urothelial carcinoma is the most common form of bladder cancer, but pathway changes that occur with stage-wise progression have not been well defined. We used a metabolomics approach to identify potential metabolic pathways uniquely altered in normal urothelium, nonmuscle-invasive bladder cancer (NMIBC), and muscle-invasive bladder cancer (MIBC). We performed global metabolomic profiling using ...
متن کاملActive surveillance for nonmuscle invasive bladder cancer
Nonmuscle invasive bladder cancer (NMIBC) is known to be a heterogeneous malignancy that requires varying treatment modalities and follow-up schedules. Low-grade Ta papillary tumors are categorized as low-risk NMIBC because of their favorable prognosis. There is an expanding movement that overdiagnosis and overtreatment should be avoided considering the economic impact and the patients' quality...
متن کاملPreclinical evaluation of VAX-IP for nonmuscle invasive bladder cancer
INTRODUCTION Bladder cancer is the second most common urothelial carcinoma worldwide, the sixth leading cause of cancer death, and the fourth most common malignancy of men in developed countries.1 An estimated 70% of bladder cancer patients present with nonmuscle invasive disease (NMIBC), with tumors confined to the mucosal surface of the uroepithelium (Ta), tumors invading the lamina propria b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Scientific World JOURNAL
سال: 2011
ISSN: 1537-744X
DOI: 10.1100/tsw.2011.28